Showing results (501-510 of 528) with videos related to

Sort By:
Pageof 53
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Emerging Infectious Diseases|July 5, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020Benjamin D Hallowell, Christina M Carlson, Jesica R Jacobs, et al.
The New England Journal of Medicine|January 29, 2015
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAKatie Ewer, Tommy Rampling, Navin Venkatraman, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Science Translational Medicine|April 6, 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Pageof 53